Institutional Fund
Saturn V Capital Management LP
Austin, TXCIK 19644375 filings on record
Portfolio Value
$552.22M
Q1 2026
Holdings
21
Reported positions
New Buys
4
Opened this quarter
QoQ Change
+1.3%
from $544.90M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Alumis Inc12.8%
- Amylyx Pharmaceuticals Inc10.9%
- Abivax SA10.9%
- Vaxcyte Inc8.7%
- Pharvaris N V6.1%
- Immix Biopharma Inc6.1%
- Other44.4%
Portfolio Holdings
21 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Alumis Inc | 3.20M | $70.54M | 12.8% | +66.1K | Added |
| 2 | Amylyx Pharmaceuticals Inc | 4.35M | $60.46M | 10.9% | −146.6K | Reduced |
| 3 | Abivax SA | 542.7K | $60.43M | 10.9% | −106.5K | Reduced |
| 4 | Vaxcyte Inc | 824.5K | $47.91M | 8.7% | +25.6K | Added |
| 5 | Pharvaris N V | 1.20M | $33.94M | 6.1% | +61.4K | Added |
| 6 | Immix Biopharma Inc | 3.69M | $33.65M | 6.1% | +694.4K | Added |
| 7 | Celcuity Inc | 281.9K | $32.18M | 5.8% | −35.2K | Reduced |
| 8 | Jazz Pharmaceuticals PLC | 163.0K | $30.81M | 5.6% | −85.1K | Reduced |
| 9 | Disc Medicine Inc | 449.9K | $28.77M | 5.2% | +151.5K | Added |
| 10 | X4 Pharmaceuticals Inc | 6.46M | $26.67M | 4.8% | +656.1K | Added |
11 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio